Revvity (NYSE:RVTY) Hits New 12-Month Low Following Analyst Downgrade

Revvity, Inc. (NYSE:RVTYGet Free Report) reached a new 52-week low on Wednesday after Raymond James lowered their price target on the stock from $145.00 to $135.00. Raymond James currently has an outperform rating on the stock. Revvity traded as low as $103.08 and last traded at $103.08, with a volume of 10868 shares. The stock had previously closed at $105.64.

RVTY has been the subject of several other reports. Robert W. Baird reduced their target price on Revvity from $165.00 to $147.00 and set an “outperform” rating for the company in a research note on Wednesday, August 2nd. Barclays reduced their price objective on shares of Revvity from $130.00 to $120.00 and set an “equal weight” rating for the company in a research report on Friday, September 29th. JPMorgan Chase & Co. dropped their target price on shares of Revvity from $130.00 to $110.00 and set a “neutral” rating on the stock in a research report on Tuesday. Finally, Sanford C. Bernstein assumed coverage on shares of Revvity in a research report on Thursday, September 28th. They set an “outperform” rating and a $133.00 price target for the company. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $129.00.

Get Our Latest Research Report on Revvity

Revvity Price Performance

The company has a market capitalization of $12.61 billion, a PE ratio of 15.53 and a beta of 1.08. The company has a debt-to-equity ratio of 0.49, a quick ratio of 2.26 and a current ratio of 2.58. The company’s fifty day moving average is $111.70.

Revvity (NYSE:RVTYGet Free Report) last issued its earnings results on Tuesday, August 1st. The company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.02. The business had revenue of $709.10 million during the quarter, compared to the consensus estimate of $708.61 million. Revvity had a return on equity of 9.06% and a net margin of 29.19%. The company’s revenue for the quarter was down 20.8% on a year-over-year basis. During the same period last year, the company earned $2.32 EPS. Research analysts anticipate that Revvity, Inc. will post 4.78 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 10th. Shareholders of record on Friday, October 20th will be issued a $0.07 dividend. The ex-dividend date is Thursday, October 19th. This represents a $0.28 annualized dividend and a yield of 0.28%. Revvity’s payout ratio is 4.28%.

About Revvity

(Get Free Report)

Revvity, Inc provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services.

Recommended Stories

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.